Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Grothey

Showing results (51-60 of 303) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|July 29, 2009
Targeting angiogenesis: progress with anti-VEGF treatment with large moleculesAxel Grothey, Evanthia Galanis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Sound footing or slippery slope? The value of secondary analyses of randomized trialsDaniel Sargent, Axel Grothey
Current Opinion in Oncology|April 9, 2010
Antiangiogenesis agents in colorectal cancerJoleen Hubbard, Axel Grothey
Therapeutic Advances in Medical Oncology|February 17, 2017
Antiangiogenic therapy for refractory colorectal cancer: current options and future strategiesRachel Riechelmann, Axel Grothey
Annals of Surgical Oncology|January 23, 2010
Adjuvant therapy for colon cancer: learning from the past to inform the futureDaniel Sargent, Axel Grothey
Mayo Clinic Proceedings|January 4, 2011
Should oncologists routinely discuss fertility preservation with cancer patients of childbearing age?Shawnta L Coleman, Axel Grothey
Current Oncology Reports|February 8, 2011
Curable metastatic colorectal cancerMatthew J Eadens, Axel Grothey
Clinical Colorectal Cancer|June 24, 2004
Oxaliplatin plus oral fluoropyrimidines in colorectal cancerAxel Grothey, Matthew P Goetz
Annals of Surgery|November 24, 2011
Adjuvant hepatic arterial infusional chemotherapy: revisiting the past or a new era?David M Nagorney, Axel Grothey
Expert Opinion on Pharmacotherapy|October 6, 2004
A review of oxaliplatin and its clinical use in colorectal cancerAxel Grothey, Richard M Goldberg
Pageof 31

Showing results (51-60 of 303) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|July 29, 2009
Targeting angiogenesis: progress with anti-VEGF treatment with large moleculesAxel Grothey, Evanthia Galanis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Sound footing or slippery slope? The value of secondary analyses of randomized trialsDaniel Sargent, Axel Grothey
Current Opinion in Oncology|April 9, 2010
Antiangiogenesis agents in colorectal cancerJoleen Hubbard, Axel Grothey
Therapeutic Advances in Medical Oncology|February 17, 2017
Antiangiogenic therapy for refractory colorectal cancer: current options and future strategiesRachel Riechelmann, Axel Grothey
Annals of Surgical Oncology|January 23, 2010
Adjuvant therapy for colon cancer: learning from the past to inform the futureDaniel Sargent, Axel Grothey
Mayo Clinic Proceedings|January 4, 2011
Should oncologists routinely discuss fertility preservation with cancer patients of childbearing age?Shawnta L Coleman, Axel Grothey
Current Oncology Reports|February 8, 2011
Curable metastatic colorectal cancerMatthew J Eadens, Axel Grothey
Clinical Colorectal Cancer|June 24, 2004
Oxaliplatin plus oral fluoropyrimidines in colorectal cancerAxel Grothey, Matthew P Goetz
Annals of Surgery|November 24, 2011
Adjuvant hepatic arterial infusional chemotherapy: revisiting the past or a new era?David M Nagorney, Axel Grothey
Expert Opinion on Pharmacotherapy|October 6, 2004
A review of oxaliplatin and its clinical use in colorectal cancerAxel Grothey, Richard M Goldberg
Pageof 31